JP6057408B2 - 癌の予防剤および/または治療剤 - Google Patents
癌の予防剤および/または治療剤 Download PDFInfo
- Publication number
- JP6057408B2 JP6057408B2 JP2012048422A JP2012048422A JP6057408B2 JP 6057408 B2 JP6057408 B2 JP 6057408B2 JP 2012048422 A JP2012048422 A JP 2012048422A JP 2012048422 A JP2012048422 A JP 2012048422A JP 6057408 B2 JP6057408 B2 JP 6057408B2
- Authority
- JP
- Japan
- Prior art keywords
- fir
- sap155
- firδexon2
- myc
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012048422A JP6057408B2 (ja) | 2012-03-05 | 2012-03-05 | 癌の予防剤および/または治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012048422A JP6057408B2 (ja) | 2012-03-05 | 2012-03-05 | 癌の予防剤および/または治療剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013184887A JP2013184887A (ja) | 2013-09-19 |
| JP2013184887A5 JP2013184887A5 (cg-RX-API-DMAC7.html) | 2015-04-23 |
| JP6057408B2 true JP6057408B2 (ja) | 2017-01-11 |
Family
ID=49386650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012048422A Active JP6057408B2 (ja) | 2012-03-05 | 2012-03-05 | 癌の予防剤および/または治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6057408B2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6304594B2 (ja) * | 2014-05-29 | 2018-04-04 | 国立大学法人千葉大学 | 芳香環含有化合物並びに癌の予防剤および/または治療剤 |
| EP3344780B1 (en) | 2015-09-01 | 2021-06-23 | Eisai R&D Management Co., Ltd. | Splice variants associated with neomorphic sf3b1 mutants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8993318B2 (en) * | 2009-12-11 | 2015-03-31 | The Brigham And Women's Hospital, Inc. | Pathogen restriction factors |
| WO2011129427A1 (ja) * | 2010-04-16 | 2011-10-20 | 第一三共株式会社 | 癌の診断剤および治療剤 |
-
2012
- 2012-03-05 JP JP2012048422A patent/JP6057408B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013184887A (ja) | 2013-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6636067B2 (ja) | c−MAFを用いた前立腺がん転移の診断、予後診断および処置のための方法 | |
| JP2010536366A5 (cg-RX-API-DMAC7.html) | ||
| KR20100075857A (ko) | 폐암의 치료 및 진단의 표적유전자인 ebi3,dlx5,nptx1 및 cdkn | |
| JP2009540803A (ja) | 癌に関与するポリヌクレオチド配列およびポリペプチド配列 | |
| Matsushita et al. | SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression | |
| EP2179286A2 (en) | Trim24 (tif1a) as p53 modulator and cancer target | |
| JP2017514514A (ja) | がんにおける融合遺伝子 | |
| Li et al. | Clusterin induced by N, N′-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis | |
| Hu et al. | Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression | |
| JP7249044B2 (ja) | 腫瘍細胞の悪性化抑制剤及び抗腫瘍剤 | |
| JP5515071B2 (ja) | 抗がん剤の作用増強剤及びその利用、並びにがん患者の予後推定用バイオマーカー及びその利用 | |
| WO2016152352A1 (ja) | メラノーマ特異的バイオマーカー及びその利用 | |
| Sun et al. | CircNSD2 promotes metastasis and immune escape by increasing the USP10/SRSF6-mediated alternative splicing of TPM1 in TNBC | |
| JP5150855B2 (ja) | Cdca1−kntc2複合体を標的とするスクリーニングおよびnsclcの治療方法 | |
| KR20240156639A (ko) | 암 진단 및 prmt5 억제제에 의한 치료 | |
| JP6519927B2 (ja) | 癌の診断、阻害剤のスクリーニングにおけるrhoaの使用 | |
| US20110027297A1 (en) | Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing | |
| JP2013184887A (ja) | 癌の予防剤および/または治療剤 | |
| Lei et al. | SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells | |
| Zhang et al. | E74-like factor 2 regulates valosin-containing protein expression | |
| WO2008044787A1 (fr) | Composition pour le traitement du cancer à l'aide de dref comme cible moléculaire | |
| US20240043557A1 (en) | A platform to obtain monoclonal antibodies directed against processed tumor-specific antigens | |
| US20110070245A1 (en) | Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer | |
| CN101664550A (zh) | 治疗或预防癌症的方法和药物 | |
| JP7250307B2 (ja) | 子宮癌の発症、転移又は再発の予測方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150304 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150304 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160404 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161028 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161122 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161202 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6057408 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |